Search arXiv⌕ Search

arXiv subjects

Shen Jia

Publications and source records attributed to Shen Jia.

3 recordsLinked to original sources

A Generalized Bayesian Approach to Clustering with Dimension Reduction

Generalized Bayes product partition models provide a probabilistic counterpart to loss-based clustering. They update a prior over partitions through an exponentiated clustering loss rather than a likelihood, so allocation uncertainty can be quantified without a full generative model for the data. However, their performance depends on the space in which the loss is evaluated. For high-dimensional observations, a squared Euclidean loss on the raw features can be dominated by irrelevant coordinates or fail to reflect cluster structure lying near a nonlinear low-dimensional manifold. We propose an extension in which an autoencoder and the partition are learned together, so that the space in which the clustering loss is evaluated is shaped by the clustering itself. Our generalized posterior combines a reconstruction loss, which keeps the low-dimensional representation faithful to the observed data, with a within-cluster sum of squares in the latent representation, which encourages cluster separation. Posterior computation alternates between Gibbs sampling over partitions and gradient-based updates of the autoencoder network, with the learning rate estimated jointly. We illustrate the approach through simulation studies and applications to four benchmark datasets.

stat.CO↗

A Novel Multi-view Mixture Model Framework for Longitudinal Clustering with Application to ANCA-Associated Vasculitis

Effectively modeling irregularly sampled longitudinal data is essential for understanding disease progression and improving risk prediction. We propose a two-view mixture model that integrates static baseline covariates and longitudinal biomarker trajectories within a unified probabilistic clustering framework. Temporal patterns are modeled using Neural Ordinary Differential Equations. Model training uses an EM algorithm with a sparsity-inducing log-penalty for interpretable subgroup discovery. Application of the model to an Irish cohort of ANCA-associated vasculitis patients reveals subgroups with heterogeneous serum creatinine trajectories and variation in end-stage kidney disease outcomes.

q-bio.QM↗

A new parsimonious method for classifying Cancer Tissue-of-Origin Based on DNA Methylation 450K data

DNA methylation is a well-studied genetic modification that regulates gene transcription of Eukaryotes. Its alternations have been recognized as a significant component of cancer development. In this study, we use the DNA methylation 450k data from The Cancer Genome Atlas to evaluate the efficacy of DNA methylation data on cancer classification for 30 cancer types. We propose a new method for gene selection in high dimensional data(over 450 thousand). Variance filtering is first introduced for dimension reduction and Recursive feature elimination (RFE) is then used for feature selection. We address the problem of selecting a small subsets of genes from large number of methylated sites, and our parsimonious model is demonstrated to be efficient, achieving an accuracy over 91%, outperforming other studies which use DNA micro-arrays and RNA-seq Data . The performance of 20 models, which are based on 4 estimators (Random Forest, Decision Tree, Extra Tree and Support Vector Machine) and 5 classifiers (k-Nearest Neighbours, Support Vector Machine, XGboost, Light GBM and Multi-Layer Perceptron), is compared and robustness of the RFE algorithm is examined. Results suggest that the combined model of extra tree plus catboost classifier offers the best performance in cancer identification, with an overall validation accuracy of 91% , 92.3%, 93.3% and 93.5% for 20, 30, 40 and 50 features respectively. The biological functions in cancer development of 50 selected genes is also explored through enrichment analysis and the results show that 12 out of 16 of our top features have already been identified to be specific with cancer and we also propose some more genes to be tested for future studies. Therefore, our method may be utilzed as an auxiliary diagnostic method to determine the actual clinicopathological status of a specific cancer.

q-bio.TO↗